CALAMOX INJECTION 0.3 GM

Calamox Injection 0.3 gm contains Co-amoxiclav as its active ingredient. Co-amoxiclav is a combination antibiotic medication consisting of amoxicillin and clavulanic acid. It is used to treat various bacterial infections caused by susceptible organisms. Amoxicillin is a penicillin-type antibiotic that works by stopping the growth of bacteria, while clavulanic acid helps to prevent the inactivation of amoxicillin by certain bacteria, thereby enhancing its effectiveness.

Side Effects:

1. Gastrointestinal effects: Common side effects of Calamox Injection may include nausea, vomiting, diarrhea, abdominal pain, and indigestion.
2. Allergic reactions: Although rare, allergic reactions to Co-amoxiclav can occur, which may manifest as skin rash, itching, swelling, or difficulty breathing. Seek immediate medical attention if any allergic symptoms occur.
3. Liver problems: Co-amoxiclav may cause liver-related side effects, such as liver inflammation or abnormal liver function tests. Consult a healthcare professional if you experience symptoms like jaundice (yellowing of the skin or eyes), dark urine, or persistent abdominal pain.
4. Blood disorders: In rare cases, Co-amoxiclav can affect blood cells, leading to conditions such as thrombocytopenia (low platelet count) or leukopenia (low white blood cell count).
5. Central nervous system effects: Co-amoxiclav may rarely cause central nervous system side effects, including headaches, dizziness, or confusion.
6. Other side effects: Other less common side effects of Calamox Injection may include vaginal yeast infections, oral thrush, or superinfection (growth of resistant bacteria or fungi).

When Not to Use:

1. Allergy or hypersensitivity: If you have a known allergy or hypersensitivity to Co-amoxiclav, amoxicillin, clavulanic acid, or any other ingredients in Calamox Injection, avoid using it.
2. Allergic reaction to penicillin or cephalosporins: Calamox Injection should be used with caution in individuals with a history of allergic reactions to penicillin or cephalosporin antibiotics, as cross-reactivity may occur.
3. Severe liver disease: Calamox Injection should be used with caution or avoided in individuals with severe liver disease or impaired liver function.
4. Infectious mononucleosis: Co-amoxiclav is generally not recommended for use in individuals with infectious mononucleosis due to the risk of developing a skin rash.
5. History of jaundice or liver problems: Inform your healthcare professional about any history of jaundice or liver problems before using Calamox Injection.

Note: The description, side effects, and contraindications provided here are general in nature. It is essential to consult a healthcare professional or refer to the product label for specific instructions, warnings, and precautions before using Calamox Injection or any other medication.